Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results

PURPOSE: Eribulin mesilate was approved for the treatment of patients with locally advanced or metastatic breast cancer (MBC), who had received at least two chemotherapeutic regimens, including anthracycline and taxane. On the other hand, the efficacy and safety information of eribulin in Korean pat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Res Treat
Hlavní autoři: Park, Yeon Hee, Kim, Tae Yong, Im, Young-Hyuck, Lee, Keun-Seok, Park, In Hae, Sohn, Joohyuk, Lee, Soo-Hyeon, Im, Seock-Ah, Kim, Jee Hyun, Kim, Se Hyun, Lee, Soo Jung, Koh, Su-Jin, Lee, Ki Hyeong, Choi, Yoon Ji, Cho, Eun Kyung, Lee, Suee, Kang, Seok Yun, Seo, Jae Hong, Kim, Sung-Bae, Jung, Kyung Hae
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Cancer Association 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398406/
https://ncbi.nlm.nih.gov/pubmed/27488876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.191
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky